BioCentury
ARTICLE | Clinical News

VBL Therapeutics preclinical data

June 11, 2012 7:00 AM UTC

In mouse models of IBD, VB-201 alleviated wasting disease and restrained gastrointestinal inflammation vs. controls. Data were presented at the Digestive Disease Week meeting in San Diego. VBL said it...